1. Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD. (15th May 2018) Authors: Mehta, Rashmi; Pefani, Eleni; Beerahee, Misba; Brealey, Noushin; Barnacle, Helen; Birk, Ruby; Zhu, Chang‐Qing; Lipson, David A. Journal: Journal of clinical pharmacology Issue: Volume 58:Number 11(2018) Page Start: 1461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Preventing clinically important deterioration with single-inhaler triple therapy in COPD. Issue 4 (3rd October 2018) Authors: Naya, Ian; Compton, Chris; Ismaila, Afisi S.; Birk, Ruby; Brealey, Noushin; Tabberer, Maggie; Zhu, Chang-Qing; Lipson, David A.; Criner, Gerard Journal: ERJ open research Issue: Volume 4:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses. Issue 2 (4th May 2018) Authors: Halpin, David M.G.; Birk, Ruby; Brealey, Noushin; Criner, Gerard J.; Dransfield, Mark T.; Hilton, Emma; Lomas, David A.; Zhu, Chang-Qing; Lipson, David A. Journal: ERJ open research Issue: Volume 4:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗